文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Allison Black
发表
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
A. Gadducci, A. Lissoni, S. Cosio, 2024, The Lancet. Oncology.